- Home
- KITT vs ABP Comparison
KITT vs ABP Comparison
Compare KITT & ABP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KITT
- ABP
- Stock Information
- Founded
- KITT 2014
- ABP 2004
- Country
- KITT United States
- ABP United States
- Employees
- KITT N/A
- ABP N/A
- Industry
- KITT Industrial Machinery/Components
- ABP Biotechnology: Pharmaceutical Preparations
- Sector
- KITT Industrials
- ABP Health Care
- Exchange
- KITT Nasdaq
- ABP Nasdaq
- Market Cap
- KITT 16.4M
- ABP 17.2M
- IPO Year
- KITT N/A
- ABP N/A
- Fundamental
- Price
- KITT $3.28
- ABP $0.20
- Analyst Decision
- KITT
- ABP Strong Buy
- Analyst Count
- KITT 0
- ABP 1
- Target Price
- KITT N/A
- ABP $4.00
- AVG Volume (30 Days)
- KITT 751.1K
- ABP 5.0M
- Earning Date
- KITT 11-11-2025
- ABP 11-18-2025
- Dividend Yield
- KITT N/A
- ABP N/A
- EPS Growth
- KITT N/A
- ABP N/A
- EPS
- KITT N/A
- ABP N/A
- Revenue
- KITT $3,082,232.00
- ABP $183,000.00
- Revenue This Year
- KITT $2,936.06
- ABP N/A
- Revenue Next Year
- KITT N/A
- ABP N/A
- P/E Ratio
- KITT N/A
- ABP N/A
- Revenue Growth
- KITT N/A
- ABP 154.17
- 52 Week Low
- KITT $2.85
- ABP $0.15
- 52 Week High
- KITT $54.36
- ABP $11.19
- Technical
- Relative Strength Index (RSI)
- KITT 54.66
- ABP 43.31
- Support Level
- KITT $2.85
- ABP $0.19
- Resistance Level
- KITT $3.65
- ABP $0.28
- Average True Range (ATR)
- KITT 0.34
- ABP 0.02
- MACD
- KITT -0.08
- ABP -0.00
- Stochastic Oscillator
- KITT 26.99
- ABP 12.12
About KITT Nauticus Robotics Inc.
Nauticus Robotics Inc develops fully electric autonomous robotic solutions for subsea applications. The company's business model includes using robotic systems for service, selling vehicles and components, and licensing related software to both the commercial and defense business sectors. The company's addressable markets include upstream, midstream, and downstream oil and gas, defense, offshore renewables, seafloor telecommunications, aquaculture, port security, oceanographic research, and subsea mining.
About ABP Abpro Holdings Inc Common Stock
Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.